技术管理办公室
大学中心塔(UCT)
7000 Fannin Street,Suite 720
德克萨斯州休斯顿77030
电话:(+1)713-500-3369
传真:(+1)713-500-0331
电子邮件:otm@uth.tmc.edu
最新技术
Researchers from UTHealth have developed a novel oncolytic viral therapy, oHSV-shPKR, which can inhibit tumor cells’ antiviral PKR activity, and increase oncolytic virus infection and replication in both oncolytic viral-resistant and sensitive cancer cells. This novel oHSV-shPKR therapy can significantly increase the anti-tumor immune response against cancer and show a striking anti-tumor effect in vivo and has the potential to become the promising oncolytic viral therapy for cancer treatment. Background Oncolytic viruses (OVs), such as oHSV, are an emerging treatment strategy f...
beplay苹果手机能用吗来自UTHEADY和俄亥俄州立大学医学院的研究人员合作研究了OHSV疗法与铂剂使用铂金高级浆液性卵巢癌(HGSOC)以及抗铂抗铂的卵巢透明细胞癌模型相结合的影响。更重要的是,他们开发了一种新型的方法,可以通过将有效量的OHSV与DNA损伤剂(例如Cisplain)共同管理,以治疗抗铂的卵巢癌。背景卵巢癌的病例型癌症比率最高。
针对oncostatin M受体(OSMR)的单克隆抗体用于治疗和诊断使用
beplay苹果手机能用吗来自UTHealth和威斯康星州医学院的研究人员合作揭示了OSMR通过激活STAT3信号传导来促进卵巢癌细胞增殖和转移的作用,并照亮了基于抗体的OSMR靶标对卵巢癌治疗的临床前疗效。尤其是,研究人员产生了抗OSMR单克隆beplay苹果手机能用吗抗体,并证明了这些抗体用于治疗和检测癌症的抗体。背景卵巢癌是最致命的妇科恶性肿瘤之一,也是第五个领先的CA。